Retransplantation in Living Donor Liver Transplantation
- PMID: 38771077
- DOI: 10.1097/TP.0000000000005072
Retransplantation in Living Donor Liver Transplantation
Abstract
The need for retransplantation after living donor liver transplantation can occur early, mainly because of technical difficulties such as hepatic artery thrombosis or as a result of early allograft dysfunction as a symptom of small-for-size syndrome. Patients with autoimmune diseases may develop progressive graft failure from recurrent disease. The ethics of retransplantation can be complicated by the cause of the initial liver disease, which may be self-inflicted or the outcome of malignancy. This is especially true in countries without the availability of deceased donors for salvage, and a second living donor would be needed. Nevertheless, patients who experience early or late graft failure should be considered for retransplant if they are deemed acceptable candidates. When a living donor is required for retransplant, the equipoise between donor risk and autonomy and recipient outcome should be considered.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no funding or conflicts of interest.
References
-
- Jackson WE, Malamon JS, Kaplan B, et al. Survival benefit of living-donor liver transplant. JAMA Surg. 2022;157:926–932.
-
- Ivanics T, Limkemann A, Patel MS, et al. Long-term outcomes of retransplantation after live donor liver transplantation: a Western experience. Surgery. 2023;173:529–536.
-
- Zakaria H, Saleh Y, Zidan A, et al. Is it justified to use liver grafts from living donors for retransplant? A single-center experience. Exp Clin Transplant. 2020;18:188–195.
-
- Hakeem AR, Mathew JS, Aunes CV, et al. Preventing small-for-size syndrome in living donor liver transplantation: guidelines from the ILTS-iLDLT-LTSI consensus conference. Transplantation. 2023;107:2203–2215.
-
- Masuda Y, Yoshizawa K, Ohno Y, et al. Small-for-size syndrome in liver transplantation: definition, pathophysiology and management. Hepatobiliary Pancreat Dis Int. 2020;19:334–341.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
